A nice mention in @fiercebiotech fiercebiotech.com/biotech/me…
1
Aronora retweeted
Congratulations to FOUR @OTRADIBio client companies for making the PBJ largest #bioscience and #healthtech companies in OR and SW WA! @HemexHealth, @aronorabio, Sonivate, and Virogenomics BioDevelopment.
#OBI4You
bizjournals.com/portland/sub…
Aronora retweeted
Thank you, @POTUS, for rejoining the #ParisAgreement and directing agencies to take action to protect public health and the environment. Portland looks forward to partnering with the Biden administration to advance climate justice and an equitable and sustainable recovery.
Aronora retweeted
@OTRADIBio is proud of @aronorabio's work and look forward to supporting them in their growth initiatives. Congratulations Aronora!
#innovation #growth #healthcare #pdx #OBI4You
bizjournals.com/portland/new…
Aronora retweeted
Replying to @TheStrokeAssoc
😯😴😕⏰🚑
I don't have the brain emoji so I have come up with this 👆
😯 for slurred speech
😴 for tired and unresponsive
😕 for facial drooping
⏰ for time for action
🚑 for phone an ambulance
#ActNow #Strokeawareness
Aronora retweeted
1 in 4 of us don't know that a stroke happens in the brain. This stops stroke survivors getting the support they need.
This #WorldEmojiDay reply to this tweet with the 🧠 emoji and help change the way people think about stroke.
Aronora retweeted
Interventions to prevent respiratory compromise in infected #COVID patients are critical. An #RPTH paper from @clotmaster and @aronorabio suggests the FXII / FXI axis as a therapeutic target for #COVID19 and suggest a potential clinical trial. Read more: onlinelibrary.wiley.com/doi/…
XOMA Acquires Royalty Rights to Five Hematology Candidates globenewswire.com/news-relea…
Large clinical trial shows that daily low dose aspirin prescribed to healthy, older patients has no benefit but does increase likelihood of hemorrhage. nejm.org/doi/full/10.1056/NE…
ATVB: An AHA Journal
@atvbahajournals
1d1 day ago
AB023, a humanized mAb that inhibits FXI activation by FXIIa, produced sustained anticoagulation without drug-related adverse events in a phase 1 clinical trial in healthy subjects.... ow.ly/L3kS30nIjT4
1
Aronora retweeted
AB023, a humanized mAb that inhibits FXI activation by FXIIa, produced sustained anticoagulation without drug-related adverse events in a phase 1 clinical trial in healthy subjects. ow.ly/L3kS30nIjT4
Another step toward a safer blood thinner. #GoTeam ahajournals.org/doi/10.1161/…
1
Wonderful 10th Anniversary Party with friends+family. Lots of milestones to be celebrated with great food + drinks. Many kudos to PLAZA DEL TORO chefs+staff!!!
1
1











